These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7931089)

  • 21. Mechanisms to induce tolerance by synthetic monosaccharide lipid A analogues against LPS lethality in mice.
    Matsuura M; Nakano M
    Prog Clin Biol Res; 1995; 392():539-48. PubMed ID: 8524962
    [No Abstract]   [Full Text] [Related]  

  • 22. D-galactosamine lethality model: scope and limitations.
    Silverstein R
    J Endotoxin Res; 2004; 10(3):147-62. PubMed ID: 15198850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model.
    Barton BE; Jackson JV
    Infect Immun; 1993 Apr; 61(4):1496-9. PubMed ID: 8454355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of complement activation in tumour necrosis factor-induced lethal hepatitis.
    Libert C; Wielockx B; Grijalba B; Van Molle W; Kremmer E; Colten HR; Fiers W; Brouckaert P
    Cytokine; 1999 Aug; 11(8):617-25. PubMed ID: 10433810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.
    Gallay P; Heumann D; Le Roy D; Barras C; Glauser MP
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7922-6. PubMed ID: 7520172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of C-reactive protein against the lethality induced by Vibrio vulnificus lipopolysaccharide.
    Chae MR; Park BH; Kim JS; Rho HW; Park JW; Kim HR
    Microbiol Immunol; 2000; 44(5):335-40. PubMed ID: 10888350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality.
    Wullaert A; Wielockx B; Van Huffel S; Bogaert V; De Geest B; Papeleu P; Schotte P; El Bakkouri K; Heyninck K; Libert C; Beyaert R
    Hepatology; 2005 Aug; 42(2):381-9. PubMed ID: 16025521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1.
    Senaldi G; Shaklee CL; Guo J; Martin L; Boone T; Mak TW; Ulich TR
    J Immunol; 1999 Dec; 163(12):6820-6. PubMed ID: 10586082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor.
    Solorzano CC; Ksontini R; Pruitt JH; Hess PJ; Edwards PD; Kaibara A; Abouhamze A; Auffenberg T; Galardy RE; Vauthey JN; Copeland EM; Edwards CK; Lauwers GY; Clare-Salzler M; MacKay SL; Moldawer LL; Lazarus DD
    J Immunol; 1997 Jan; 158(1):414-9. PubMed ID: 8977217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential response of a(2)-macroglobulin-deficient mice in models of lethal TNF-induced inflammation.
    Hochepied T; Ameloot P; Brouckaert P; Van Leuven F; Libert C
    Eur Cytokine Netw; 2000 Dec; 11(4):597-601. PubMed ID: 11125302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of (2E)-3-[5-(2,3-dimethoxy-6-methyl-1,4- benzoquinoyl)]-2-nonyl-2-propenoic acid on endotoxin-mediated hepatitis in mice.
    Nagakawa J; Hishinuma I; Miyamoto K; Hirota K; Abe S; Yamanaka T; Katayama K; Yamatsu I
    J Pharmacol Exp Ther; 1992 Jul; 262(1):145-50. PubMed ID: 1625194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice.
    Dejager L; Libert C
    Cytokine; 2008 Apr; 42(1):55-61. PubMed ID: 18331798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
    Brouckaert P; Everaerdt B; Fiers W
    Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavonoids protect mice from two types of lethal shock induced by endotoxin.
    Takahashi K; Morikawa A; Kato Y; Sugiyama T; Koide N; Mu MM; Yoshida T; Yokochi T
    FEMS Immunol Med Microbiol; 2001 Jul; 31(1):29-33. PubMed ID: 11476978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways.
    Bohlinger I; Leist M; Barsig J; Uhlig S; Tiegs G; Wendel A
    Hepatology; 1995 Dec; 22(6):1829-37. PubMed ID: 7489995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-1 alpha enhances hepatotoxicity of tumor necrosis factor-alpha in galactosamine-sensitized mice.
    Nagakawa J; Hishinuma I; Hirota K; Miyamoto K; Yasuda M; Yamanaka T; Katayama K
    Immunopharmacol Immunotoxicol; 1991; 13(4):485-98. PubMed ID: 1774433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.
    Leist M; Gantner F; Bohlinger I; Tiegs G; Germann PG; Wendel A
    Am J Pathol; 1995 May; 146(5):1220-34. PubMed ID: 7538266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polydatin protects against lipopolysaccharide-induced fulminant hepatic failure in D-galactosamine-sensitized mice.
    Wu MJ; Gong X; Jiang R; Zhang L; Li XH; Wan JY
    Int J Immunopathol Pharmacol; 2012; 25(4):923-34. PubMed ID: 23298483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway.
    Le Roy D; Morand P; Lengacher S; Celio M; Grau GE; Glauser MP; Heumann D
    Infect Immun; 1996 May; 64(5):1846-9. PubMed ID: 8613401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.